Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07735377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer

Name: A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer — clinical trial record (NCT07735377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorSuzhou Suncadia Biopharmaceuticals Co., Ltd.

Started2026-08-26

View on ClinicalTrials.gov ↗

Trial flagged as At Risk

Primary completion moved at least 3 months later Aug 2026 → Dec 2026

See other at-risk trials from Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Amendment history

2026-09-03

Study Status v2

Primary completion pushed: 2026-08 → 2026-12

Start dateestimated 2026-08→confirmed 2026-08-26

2026-08-19

Study Status, Contacts/Locations v1

Recruitment opened

Study sitesdetails revised at 1 of 1 site

2026-07-24

Original filing

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

75 trials monitored

See 7 trials at risk

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

This is a phase 1 study to assess the safety and tolerability of SHR-6914 as monotherapy therapy in adult subjects with prostate cancer.

Trial Details

NCT Number	NCT07735377
Lead Sponsor	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions	Prostate Cancer
Enrollment	118 participants
Start Date	2026-08-26
Primary Completion	2026-12 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-09-08